Particle News: Latest Pfizer news

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. From Wikipedia

HHS Mandates Placebo Trials for New Vaccines, Including Covid Boosters

The new policy, announced under Robert F. Kennedy Jr., is expected to delay vaccine rollouts, raising concerns for vulnerable populations.

Same-Arm Boosters Found to Enhance Early Vaccine Response

Merck in Advanced Talks to Acquire Springworks Therapeutics for $3.5 Billion

HHS Secretary RFK Jr. Weighs Removing COVID-19 Vaccine From Childhood Schedule

Pfizer Halts Development of Danuglipron After Liver Safety Concerns

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

Federal Investigation Examines Claims of Pfizer Vaccine Announcement Delay in 2020

Pfizer Completes £2.5 Billion Sale of Remaining Stake in Haleon

Senators Question RFK Jr.'s Mar-a-Lago Dinners with Big Pharma Executives

Moderna Wins Patent Case Against BioNTech and Pfizer Over mRNA Technology

Pfizer Considers Relocating Overseas Manufacturing to U.S. Facilities

Anthropic Secures $3.5 Billion in Funding, Reaching $61.5 Billion Valuation

GSK Proposes Doubling CEO Emma Walmsley’s Pay to $27 Million

HHS Reconsiders $590 Million Moderna Contract for Bird Flu Vaccine

Study Finds Paxlovid Offers Limited Benefits for Vaccinated Seniors

LL Cool J's 'Mama Said Knock You Out' Powers Pfizer's Super Bowl Ad on Cancer Fight

Pfizer Reports Strong Q4 Earnings But Faces Uncertain Market Sentiment

Pfizer Exceeds Q4 Earnings Expectations with Strong Covid Product Sales and Cost Cuts

Anti-DEI Movement Gains Momentum Targeting Major Corporations and Federal Workforce

France Recommends Pneumococcal Vaccination for All Seniors Aged 65 and Older

Pfizer Settles $59.7M Kickback Allegations Tied to Acquired Migraine Drug

Activist Investor Starboard Value Acquires 7.7% Stake in Qorvo

Pfizer Ends Hemophilia Gene Therapy Partnership With Sangamo, Sending Stock Plummeting

BioNTech and Pfizer Agree to $1.2 Billion Settlement Over U.S. Vaccine Patent Disputes

BioNTech Settles COVID-19 Vaccine Royalty Disputes for $1.2 Billion

Merck Secures $2 Billion Deal for Experimental Oral Weight Loss Drug from Hansoh Pharma

Vaccine Companies See Stock Decline After Trump's Health Secretary Pick

UK Conspiracy Theorist Jailed for Promoting Violence During Pandemic

Canada Approves Moderna's mRNA RSV Vaccine for Seniors

Pfizer's Strong Q3 Earnings Challenge Activist Investor's Push for Change

Kenvue Stock Jumps as Starboard Value Takes Significant Stake

France Launches Dual Covid-19 and Flu Vaccination Campaign

Pfizer Faces Activist Pressure as Ex-Execs Withdraw Support for Starboard

RSV Vaccine Sales Decline Sharply in U.S. Amid Narrowed Eligibility

Starboard Value Acquires $1 Billion Stake in Pfizer

Pfizer Sells £2.4 Billion Stake in Haleon, Reducing Holding to 15%

Pfizer Withdraws Sickle Cell Drug Oxbryta Over Safety Concerns

Health Canada Approves Pfizer's Updated COVID-19 Vaccine

Health Canada Approves Updated Novavax COVID-19 Vaccine for Fall

Health Canada Approves Moderna's Updated COVID-19 Vaccine

Pfizer's New Drug Shows Promise in Combatting Cancer-Related Weight Loss

New COVID Surge and Updated Vaccines Prompt Renewed Precautions

Convicted Fraudsters Jacob Wohl and Jack Burkman Launch Dubious AI Lobbying Firm

Alnylam's Vutrisiran Shows Mixed Results in Cardiomyopathy Study

Ozempic Likely Target for 2027 Medicare Price Negotiations

Free At-Home COVID Tests to Resume in September

FDA Approves Updated COVID-19 Vaccines Targeting New Variants

FDA Expected to Approve New COVID-19 Vaccine Amid Rising Cases

COVID-19 Vaccinations Linked to Reduced Heart Attack and Stroke Risks

Moderna Lowers Annual Sales Forecast Amid Competitive Vaccine Market

Dividend Stocks Primed for Gains as Interest Rates Set to Fall

Pfizer and Merck Diverge in Q2 Performance Amid Revised Forecasts

Brian Lesser Returns as Global CEO of GroupM

Pfizer Advances Daily Weight Loss Pill Amid FDA Rejection of Novo's Insulin

Weight Loss Drug Adherence Drops, Companies Push for Oral Alternatives

GSK Acquires CureVac's mRNA Vaccines for COVID-19, Flu

CDC Updates RSV Vaccine Guidance for Older Adults

NHS to Offer RSV Vaccine to Pregnant Women and Elderly This Autumn

Kansas Sues Pfizer Over Misleading COVID-19 Vaccine Claims

FDA Advisers Recommend JN.1-Based COVID Vaccine for Fall

GSK Faces Major Legal Setback as 70,000 Zantac Lawsuits Proceed

Pfizer's Lorbrena Sets New Benchmark in Treating Advanced Lung Cancer

US Government Nears Funding Deal for Moderna's mRNA Bird Flu Vaccine

New mRNA Vaccines Under Development to Combat Bird Flu in Cows and Humans

Pfizer Announces $1.5 Billion Cost-Cutting Plan Amid Falling Vaccine Demand

GSK Completes £1.2 Billion Sale of Remaining Haleon Stake

Pfizer Agrees to $250 Million Settlement Over Zantac Cancer Lawsuits

France Secures Record $16 Billion in Foreign Investments at Choose France Summit

Pfizer Settles Thousands of Zantac Cancer Lawsuits

Pfizer Raises 2024 Profit Forecast Amid Strong Quarterly Performance

Moderna, Pfizer, BioNTech Clash in UK Court Over COVID-19 Vaccine Patents

Pfizer Seeks FDA Approval for RSV Vaccine in Young Adults

China's New Pledge to Foreign Firms Met With Skepticism

BioNTech Faces Sharp Decline in Vaccine Demand, Shifts Focus to Oncology

Pfizer to Sell £2 Billion Stake in Consumer Health Giant Haleon

Investigation Underway into RSV Vaccines and Guillain-Barré Syndrome Link

Pfizer's RSV Vaccine Shows Sustained Efficacy in Older Adults

Viking Therapeutics' Stock Soars on Promising Weight-Loss Drug Results

Drug Prices Surge in 2023 Despite Biden Administration Efforts

WPP Reports Sharp Profit Decline Amid Tech Spending Cuts, Invests Heavily in AI

NHS to Offer First-Ever Alopecia Treatment After NICE Approval

FDA Clarifies COVID-19 Vaccine Recipients Can Donate Blood